Cargando…
Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination
Individuals infected with the human immunodeficiency virus type 1 (HIV-1) belong to the group of people most vulnerable to SARS-CoV-2 infections and the associated disease COVID-19. Here we describe SARS-CoV-2-specific antibody and cellular immune responses in a small cohort of immunological non-res...
Autores principales: | Sisteré-Oró, Marta, Andrade, Naina, Wortmann, Diana D.J., Du, Juan, Garcia-Giralt, Natalia, González-Cao, María, Güerri-Fernández, Robert, Meyerhans, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459333/ https://www.ncbi.nlm.nih.gov/pubmed/36091014 http://dx.doi.org/10.3389/fimmu.2022.994173 |
Ejemplares similares
-
Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination
por: Sisteré-Oró, Marta, et al.
Publicado: (2022) -
Comparative Transcriptional Analysis Identified Characteristic Genes and Patterns in HIV-Infected Immunological Non-Responders
por: Liu, Xiaosheng, et al.
Publicado: (2022) -
HIV-Sheltering Platelets From Immunological Non-Responders Induce a Dysfunctional Glycolytic CD4(+) T-Cell Profile
por: Zhu, Aiwei, et al.
Publicado: (2022) -
Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4(+) T Cells in HIV-Infected Immunological Non-Responders
por: Lorvik, Kristina Berg, et al.
Publicado: (2021) -
Add-on Pyridostigmine Enhances CD4(+) T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study
por: Valdés-Ferrer, Sergio I., et al.
Publicado: (2017)